Hamlet BioPharma AB (publ), the pharmaceutical company with a strong portfolio of projects for the treatment of cancer and infections, shares an updat...
Lund, Sweden, November 29, 2023. Hamlet BioPharma AB (publ), the pharmaceutical company with a strong portfolio of projects for the treatment of cance...
Aktieägarna i Hamlet BioPharma AB (”Bolaget”), org.nr 556568-8958, kallas härmed till extra bolagsstämma torsdagen den 14 december 2023 klockan 16:30 ...
Aktieägarna i Hamlet BioPharma AB (”Bolaget”), org.nr 556568-8958, kallas härmed till årsstämma torsdagen den 14 december 2023 klockan 15:00 på High C...
The company was presented by Catharina Svanborg and Jan Zetterberg.
To view the presentation, please use the link bekow:
https://youtu.be/zkZsCx0y1Qw?...
Hamlet Biopharma vill meddela att bolagets årliga bolagsstämma planeras att äga rum den 14 december 2023.
Åsredovisning kommer att offentliggöras inna...
Professor Gabriela Godaly is working with Hamlet BioPharma to develop a new therapeutic concept to combat tuberculosis through the use of a bacteric...
Hamlet BioPharma, the pharmaceutical company with a strong portfolio of projects for the treatment of cancer and infections, announces the results for...
